Chemomab Therapeutics Ltd ADR (NASDAQ: CMMB) flaunted slowness of -16.20% at $1.19, before settling in for the price of $1.42 at the close. Taking a more long-term approach, CMMB posted a 52-week range of $0.42-$1.58.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 0.00%. Meanwhile, its Annual Earning per share during the time was -13.49%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -268.93%. This publicly-traded company’s shares outstanding now amounts to $14.20 million, simultaneously with a float of $11.98 million. The organization now has a market capitalization sitting at $16.92 million. At the time of writing, stock’s 50-day Moving Average stood at $1.0280, while the 200-day Moving Average is $0.7537.
Chemomab Therapeutics Ltd ADR (CMMB) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Chemomab Therapeutics Ltd ADR industry. Chemomab Therapeutics Ltd ADR’s current insider ownership accounts for 15.76%, in contrast to 2.96% institutional ownership.
Chemomab Therapeutics Ltd ADR (CMMB) Earnings and Revenue Records
Chemomab Therapeutics Ltd ADR’s EPS decrease for this current 12-month fiscal period is -268.93% and is forecasted to reach -0.37 in the upcoming year.
Chemomab Therapeutics Ltd ADR (NASDAQ: CMMB) Trading Performance Indicators
Let’s observe the current performance indicators for Chemomab Therapeutics Ltd ADR (CMMB). It’s Quick Ratio in the last reported quarter now stands at 3.83. The Stock has managed to achieve an average true range (ATR) of 0.14.
In the same vein, CMMB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.60, a figure that is expected to reach -0.10 in the next quarter, and analysts are predicting that it will be -0.37 at the market close of one year from today.
Technical Analysis of Chemomab Therapeutics Ltd ADR (CMMB)
Now, what If we examine the latest scores posted by [Chemomab Therapeutics Ltd ADR, CMMB]. During the last 5-days, its volume was better the volume of 0.18 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 65.97% While, its Average True Range was 0.1616.
Raw Stochastic average of Chemomab Therapeutics Ltd ADR (CMMB) in the period of the previous 100 days is set at 61.04%, which indicates a major rise in contrast to 40.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 115.24% that was higher than 107.38% volatility it exhibited in the past 100-days period.
